Alembic Pharma Shares Slump 2% as Vadodara Unit Gets One Observation
Shares of Alembic Pharmaceuticals Ltd slumped as much as 2.8% on Monday, 10 March, after the company’s Bioequivalence facility in Vadodara was inspected by the...
Tag : USFDA observations
Gland Pharma Receives Three Observations from USFDA
Gland Pharma Ltd announced on Tuesday, 25 February, that the U.S. Food and Drug Administration (USFDA) has completed a key inspection of its Andhra Pradesh...
Laurus Labs Shares Gain 2% Despite Receiving Arm Receiving One Observation
Shares of Laurus Labs Ltd rose 2% on 23 January despite the USFDA issuing one observation regarding the company’s overseas subsidiary. The US Food and...
Lupin Shares Slump 2% on Receiving 5 Observations from USFDA
Shares of Lupin Ltd were trading in the red and 2% lower on 7 October after the company announced receiving 5 observations from the USFDA. ...
Aurobindo Pharma Shares Drop 2.5% After USFDA Issues 10 Observations to Telangana API Unit
Shares of Aurobindo Pharma Ltd. fell by 2.5% after reaching a day’s high of Rs 1,518.90 on 30th September, following the company’s announcement that the...
Lupin Shares Slump 1% as Pithampur Facility Receives 3 Observations
Shares of Lupin Ltd were trading in the red and 1.75% lower on 30 September after the company announced that its Pithampur facility in Madhya...
Granules India Shares Fall 8% on 6 USFDA Observations
Shares of Granules India Ltd. fell 8% after reaching a day’s high of Rs 690 on 12th September, following six USFDA observations issued to the...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Zydus Lifesciences Shares Slump 5% as Unit Receives Ten Observations
Shares of Zydus Lifesciences were trading in the red and 5% lower on 24 April after the company’s injectables production plant received ten observations from...
Aurobindo Pharma Shares Slump 1% as Arm Receives 3 Observations
Shares of Aurobindo Pharma Ltd were trading in the red and 1.5% lower on 8 April after the company announced receiving three observations from USFDA....
